Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson's Disease to the Clinic: The Investigator's Perspective. (2021)

First Author: Barker R
Attributed to:  The Pluripotent Stem Cells and Engineered Cell (PSEC) Hub funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.65980

Publication URI: https://www.repository.cam.ac.uk/handle/1810/318865

Type: Journal Article/Review